Dear Abhishek and Mr. Suresh,
Let me kindly inform you that the provided draft letter of Agreement does not cover the required provisions necessary to formalize contractual relations between our parties. Therefore, I would like to share with you our draft procurement agreement for your revision. Please kindly send your comments/suggestions ASAP.
As for the import license, please note that according to the sub-paragraph „a“ of the Article 1113 of Georgian Law on “Medicines and Pharmaceutical Activities”, pharmaceutical product may be imported circumventing the regimes for granting marketing authorisation in Georgia for non-commercial purposes in case of pre-clinical and clinical trials. The medicine “Remdesivire” will be used within the “Solidarity Trial” and consequently, import license is not required.
Hereby, please be informed that in the attached draft Agreement is mentioned that the procured medication will be used only for non-commercial purposes by the medical facilities involved in the trial. However, if you still require the confirmation letter, the AIDS Center will proceed.
Looking forward to receiving your feedback.
Thank you once again for continued cooperation and support.
From: Abhishek Datta <Abhishek.Datta@mylan.in>
Sent: Wednesday, October 21, 2020 9:16 AM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Suresh Karavadi <Suresh.Karavadi@mylan.in>
Subject: RDV - Georgia
Dear Maia
As discussed, please find attached draft copy of agreement.
We need 2 inputs from your side:
- Import License for Georgia
- Confirmation that the stocks will not be supplied to any Wholesaler/Distributor locally
Please do let us know if you have any questions. Mr. Suresh marked in CC is from our legal team, he will help in case you need any clarity from legal point of view.
Warm Regards,
Abhishek
| |||
| Please think before you print. |
| |
From: Maia Nikoleishvili
Sent: Tuesday, October 20, 2020 3:13 PM
To: Jaspal Singh Virk <JaspalSingh.Virk@mylan.com>
Cc: 'Abhishek Datta' <Abhishek.Datta@mylan.in>; Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Ekaterine Adamia <eadamia@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; inf.procurement@gmail.com; akaki abutidze <akakiabutidze@yahoo.com>; Sudhir Desai <Sudhir.Desai@mylan.in>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Dear Jaspal,
We are looking forward to receiving the first draft of the contract for internal revision.
If there is any other provisions to be added from you side, you can include later.
Ambassador of Georgia to India informed us that the Charter flight might be arranged on 29th of October, therefore, it’s highly important to complete all internal procedures related to the delivery ASAP. We hope as well that the export license will be obtained before the end of this week.
Please, kindly send the draft contract as early as possible.
Thank you in advance.
Best regards,
Maia
From: Abhishek Datta <Abhishek.Datta@mylan.in>
Sent: Friday, October 16, 2020 2:52 PM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>; Jaspal Singh Virk <JaspalSingh.Virk@mylan.com>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Ekaterine Adamia <eadamia@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; inf.procurement@gmail.com; akaki abutidze <akakiabutidze@yahoo.com>; Sudhir Desai <Sudhir.Desai@mylan.in>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High
Dear Maia
We confirm the receipt of PO. As discussed, we will apply for export license immediately.
As for agreement we have shared the details with our legal team. They will share the draft shortly.
Dear Jaspal
As discussed, can you please apply for export license immediately. Ms. Maia said if you can share the details of concerned person/team who issue export license they can try from their side for faster approval.
So, kindly share the details with them.
Also, we need to plan for dispatch as soon as we get export license.
Warm Regards,
Abhishek
From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Friday, October 16, 2020 3:08 PM
To: Abhishek Datta <Abhishek.Datta@mylan.in>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Ekaterine Adamia <eadamia@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; inf.procurement@gmail.com; akaki abutidze <akakiabutidze@yahoo.com>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear Abhishek,
Please, find the enclosed PO for 4000 vial Remdesivir signed by the Infectious Diseases, AIDS and Clinical Immunology Research Center.
Considering current epidemiological situation, we kindly request you to rapidly finalize formal procedures necessary for obtaining export license and consequently, to deliver the goods as early as possible.
Meanwhile, please share your draft contract and we will provide our suggestions and comments.
Thank you once again for your efforts and continued support.
Best regards,
Maia
From: Abhishek Datta <Abhishek.Datta@mylan.in>
Sent: Thursday, October 15, 2020 5:03 PM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Ekaterine Adamia <eadamia@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; inf.procurement@gmail.com; akaki abutidze <akakiabutidze@yahoo.com>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Dear Maia
Please share us the PO for 4K as mentioned below.
The PO additional quantity will be only used for applying Export License & there will be no obligation to purchase full quantity.
Warm Regards,
Abhishek
From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Thursday, October 15, 2020 6:05 PM
To: Abhishek Datta <Abhishek.Datta@mylan.in>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge; Ekaterine Adamia <eadamia@moh.gov.ge>; Tinatin Khardziani <tkhardziani@moh.gov.ge>; Beka Jakeli <bjakeli@moh.gov.ge>; inf.procurement@gmail.com; akaki abutidze <akakiabutidze@yahoo.com>
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear Abhishek,
Hope you are doing well.
Please, be kindly informed that the Ministry is going to procurer initially 4000 vials of Remdesivir 100 mg through Infectious Diseases, AIDS and Clinical Immunology Research Center, which is a state-owned hospital. Therefore, the PO will be sent on behalf of the AIDS Center.
In addition, kindly request you to confirm that by indicating increased amount of Remdesivir in the PO, it will not impose an obligation to purchase full quantity. As I understand, this procedure is necessary only for submission to the export license and in case of additional order we will avoid to go through this procedure again.
Looking forward to receiving you feedback.
Best regards,
Maia
From: Abhishek Datta <Abhishek.Datta@mylan.in>
Sent: Tuesday, October 13, 2020 6:33 PM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Hi Maia
Please find attached 2 sets of Carton, Label & PIL from our 2-manufacturing facility
Warm Regards,
Abhishek
From: Abhishek Datta
Sent: Tuesday, October 13, 2020 7:35 PM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Dear Maria
As discussed, please find attached WHO GMP, CoA & COC & Free Sales Certificate.
Do let us know if you need any other documents.
Warm Regards,
Abhishek
From: Abhishek Datta
Sent: Tuesday, October 13, 2020 3:07 PM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High
Dear Ms. Maria
It was good to connect with you!
As discussed, we need to apply for Export License before we make any commercial supplies. For applying Export license, we need a dummy Purchase Order on your letter head may be with some extra quantity like 100,000 vials. We will use this purchase order only for applying export license not for commercial supplies.
Mylan has license from Gilead to supply to Georgia. The final price offer would be USD 26.00/vial (CIP Tbilisi)
We agree with the payment terms.
Please share us the list of documents you need from our side.
Warm Regards,
Abhishek
From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Tuesday, October 13, 2020 12:51 PM
To: Abhishek Datta <Abhishek.Datta@mylan.in>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear Mr. Abhishek,
Many thanks for your prompt reply.
As we agreed over the phone, please kindly review the price and offer discount, the lowest possible price.
Please, also clarify the terms of delivery and inform us procedure necessary for immediate dispatching the goods.
As for the payment terms, please note that since we are governmental organization, it would be difficult for us to pay the total value of goods in advance. Therefore, kindly request you to consider payment after delivery or 20 percent in advance and 80 percent after receiving the goods.
And also send me all documentation related to the medication.
Thank you once again for your readiness to support Georgia and I believe that this cooperation will be beneficial for both of our sides.
Best regards,
Maia
+995 577272713 (WhatsApp number)
From: Abhishek Datta <Abhishek.Datta@mylan.in>
Sent: Tuesday, October 13, 2020 9:10 AM
To: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Cc: Elena Magura <elena.magura@mylan.com>; Prashant Deshpande <Prashant.Deshpande@mylan.in>; Harpal Singh <harpal.singh@mylan.com>; Tamar Gabunia <tgabunia@moh.gov.ge>; a.dzuliashvili@mfa.gov.ge
Subject: RE: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High
Dear Maria
Greetings from Mylan!
Thanks for sharing your requirements for Remdesivir.
We would be glad to offer 3000 Vials for 500 patients (i.e. 6 vials/patients). The delivery timelines would be 2-3 weeks (depending of receipt of Export License for Georgia).
The offer price would be USD 28.00/vial (Incoterms: CIF Tbilisi).
Please do let us know if you need any other information or documents from our side. My contact details are shared in my below signature.
Looking forward to hearing from you!
Warm Regards
Abhishek Datta
Business Development
Mylan Laboratories Limited
Hyderabad, India
Direct +91 40 3086 6265
Mobile +91 8008553783
From: Maia Nikoleishvili <mnikoleishvili@moh.gov.ge>
Sent: Saturday, October 10, 2020 3:38 PM
To: Mylan Customer Service <customer.service@mylanlabs.com>; Communications India and EM <Communicationsinem@mylan.com>
Cc: Tamar Gabunia <tgabunia@moh.gov.ge>; Archil Dzuliashvili <a.dzuliashvili@mfa.gov.ge>
Subject: Request from MoH Georgia regarding procuring Remdesivir from Mylan
Importance: High
CAUTION: This email originated from outside of the company. Do not click links or open attachments unless you recognize the sender and know the content is safe.
Dear Sirs,
I would like to kindly address you from the Ministry of Internally Displaced Persons from the Occupied Territories, Labour, Health and Social Affairs of Georgia regarding procuring generic form of Remdesivir manufactured by Mylan under a license from Gilead Science Inc.
Considering current epidemiological situation, we are committed to use all existing opportunities, including engagement in the study of Remdesivir for the treatment of the patients with severe acute respiratory syndrome of COVID-19 in order to avoid fatal outcomes in the infected patients as far as possible.
Therefore, we urgently need to procurer Remdesivir, initially sufficient for 500 eligible patients and kindly request you to provide us with the product price as well as terms and conditions of delivery as early as possible.
We rely on your support and do hope that our cooperation will be fruitful and successful.
Looking forward to receiving your feedback as soon as possible.
Sincerely yours,
Maia Nikoleishvili MPA
Head of International Relations and Protocol Division
Ministry of IDPs from the Occupied Territories, Labour, Health and Social Affairs of Georgia
Address: 144 Tsereteli ave., 0159 Tbilisi, Georgia
Tel.: +995 32 2510034 (0803)
Cell phone: +995 577272713
E-mail: mnikoleishvili@moh.gov.ge
| |||
| Please think before you print. |
| |